NYMC Faculty Publications

Comparison of Intraspinal and Intrathecal Implantation of Induced Pluripotent Stem Cell-Derived Neural Precursors for the Treatment of Spinal Cord Injury in Rats

Author Type(s)

Faculty

DOI

10.1186/s13287-015-0255-2

Journal Title

Stem Cell Research & Therapy

First Page

257

Last Page

257

Document Type

Article

Publication Date

12-22-2015

Department

Neurosurgery

Keywords

Animals, Cell Differentiation, Cell Survival, Induced Pluripotent Stem Cells, Injections, Spinal, Locomotion, Male, Nerve Regeneration, Nerve Tissue Proteins, Neural Stem Cells, Paracrine Communication, Rats, Rats, Wistar, Spinal Cord Injuries

Disciplines

Medicine and Health Sciences

Abstract

BACKGROUND: Stem cell treatment provides a promising therapy for patients with spinal cord injury (SCI). However, the applied stem cells exert their effects in different manners that are dependent on the route used for administration.

METHODS: In the present study, we administered neural precursors derived from induced pluripotent stem cells (iPS-NPs) either intraspinally into the lesion center or intrathecally into the subarachnoid space of rats with a balloon-induced spinal cord compression lesion. Functional locomotor performance, cell survival, astrogliosis, axonal sprouting and the expression of endogenous neurotrophic growth factors were evaluated using behavioral tests (BBB, flat beam test, rotarod, plantar test), morphometric analysis, immunohistochemistry and qPCR.

RESULTS: Both treatments facilitated the functional locomotor recovery of rats with SCI. iPS-NPs injected intraspinally survived well for 2 months and were positive for MAP2, while cells grafted intrathecally were undetectable at the site of administration or in the spinal cord tissue. Intraspinal implantation increased gray and white matter sparing and axonal sprouting and reduced astrogliosis, while intrathecal application resulted only in an improvement of white matter sparing and an increase in axonal sprouting, in parallel with no positive effect on the expression of endogenous neurotrophic growth factor genes or glial scar reduction.

CONCLUSIONS: Intrathecally grafted iPS-NPs had a moderate therapeutic benefit on SCI through a paracrine mechanism that does not require the cells to be present in the tissue; however, the extended survival of i.s. grafted cells in the spinal cord may promote long-term spinal cord tissue regeneration.

Link to Full Text

Share

COinS